KeyPlants has signed an agreement with one of the worlds’ largest pharmaceutical companies! We will support their organisation in building a modular vaccine facility for drug substance manufacturing and fill finish. The facility will be delivered already in early 2021 and be producing hundreds of millions of vaccine doses when operational. The facility will be designed and manufactured by KeyPlants’ in Sweden.